Commission Decision of 17 December 1992 concerning the specific financial contribution by the Community towards the eradication of African horse sickness in Morocco
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Kingdom of Morocco may obtain a financial contribution from the Community for the acquisition of the African horse sickness vaccine used for the vaccination measures carried out between 1 May 1992 and 31 July 1992 in the provinces of Tanger, Tetouan, Larache, Kenitra, Sidi-Kacem, Taounate, Chefch ouen and Al-Hoceima.
The financial contribution provided for in Article 1 shall be granted subject to the Moroccan authorities implementing or having implemented the following measures in the provinces listed in Article 1: - application of a compulsory vaccination programme using a Type 4 vaccine on all equidae, - registration of the owners of equidae, - identification of equidae at the time of vaccination by a mark in the shape of a 'V' at least 35 mm high and 30 mm wide made on the skin by means of freeze branding. However, registered horses identified by means of a passport recognized at international level may be marked by tattooing on the lip, - introduction of a system under which it is compulsory to declare the death of equidae, - immediate slaughter without compensation of equidae which are not marked and are not vaccinated against African horse sickness, - organization of an information campaign for the benefit of breeders and veterinarians with a view to stressing the importance of vaccination for equidae and, in particular, foals, and the need for all deaths to be declared to the competent authorities, - making available to the Community reference laboratory 20 doses from each batch of vaccine used.
The financial contribution by the Community shall be fixed at 100 % of the expenses incurred by the Kingdom of Morocco for the acquisition of the vaccine.
1. The Community's financial contribution shall be granted after: - a report on the implementation of the measures referred to in Article 2 has been forwarded to the Commission, - supporting documents relating to the acquisition of and payment for the vaccine used in accordance with Article 1 have been presented. 2. The documents referred to in paragraph 1 shall be forwarded by the Kingdom of Morocco by 18 December 1992 at the latest.
This Decision is addressed to the Member States. Done at Brussels, 17 December 1992. For the Commission Ray MAC SHARRY Member of the Commission (1) OJ No L 224, 18. 8. 1990, p. 19. (2) OJ No L 356, 24. 12. 1991, p. 1.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.